Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, -2, and -3
Journal of the American Academy of Dermatology Mar 20, 2018
Egeberg A, et al. - The cardiovascular-related parameters were investigated in psoriasis patients treated with ixekizumab. Findings showed a neutral effect of ixekizumab on cardiovascular-related parameters in patients having psoriasis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
